Abolishing mammography screening programs? A view from the Swiss Medical Board.

  title={Abolishing mammography screening programs? A view from the Swiss Medical Board.},
  author={Nikola Biller-Andorno and Peter J{\"u}ni},
  journal={The New England journal of medicine},
  volume={370 21},
In February, the Swiss Medical Board recommended that no new systematic mammography screening programs be introduced, that time limits be put on current programs, that screening quality be evaluated, and that women be given clear information regarding benefits and harms. 

Topics from this paper

Paper Mentions

Interventional Clinical Trial
Mammography remains an imperfect screening test especially in women with extremely dense breast tissue, missing biologically aggressive cancers especially in younger population and… Expand
ConditionsBreast Cancer
Screening mammography guidelines: an alternative proactive approach.
In this opinion piece, I suggest that we breast imagers modify our initial interpretations and our downstream recommendations for screening mammograms, thereby reducing recall rates, percutaneousExpand
Viewpoint: It is time to reconsider policy for population-based mammography screening
There is no reliable evidence that population-based mammography screening reduces mortality, but there is good evidence of harm in the form of false positive findings, over-diagnosis and unnecessary treatment, and associated psychological distress. Expand
Screening mammography: sparing the emperor's blushes
Differing interpretations about evidence on benefits and harms of screening mammography has led to conflicting recommendations among different jurisdictions that range from intensive screeningExpand
Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality
  • A. Barratt
  • Medicine
  • BMJ : British Medical Journal
  • 2015
Alexandra Barratt summarises and debates overdiagnosis in breast cancer screening and discusses how myriad uncertainties might be resolved so we can move forward
Abolishing mammography screening programs?
It is accepted that there are still uncertainties in the absolute and relative impact of mammography screening on breast cancer mortality, given the different study schemes and mammography intervals, the differences in populations, and the continuous improvements in technology. Expand
The Great Mammography Debate
The controversy over mortality benefits from screening arise principally from a single trial, the Canadian National Breast screening study (CNBss), which is an outlier trial in that it failed to demonstrate any benefit of mammography over clinical breast exam. Expand
Mammography screening 2.0 - translating risk adapted screening into clinical practice
The research shows that an individualized risk adapted screening strategy is feasible and of advantage in clinical practice and could contribute to the evidence required to overcome any barriers associated with replacing the current “all inclusive” age related screening guidelines with a more focused individualized approach, which requires medical counseling. Expand
Physician Perspectives on Mammography Screening for Average-Risk Women: “Like a Double-Edged Sword”
Although POEMs about mammography screening raise awareness of harms and benefits, deeply rooted ideas illustrate how any change process is complex, rethinking breast cancer screening for average-risk women is challenging. Expand
Understanding breast cancer screening--past, present, and future.
An up-to-date overview of breast cancer mammography screening is provided and the focus should be on providing sufficient information about the pros and cons of screening to help women make a personal, informed choice. Expand


Women's perception of mammography screening.
Concerns are raised about the design and conclusions of the study on women’s perception of the benefits of mammography screening in four countries, and the possible confusion around the term prevention which was understood by some as ‘prevents the development of a breast cancer toward a fatal outcome’. Expand
Quantifying the benefits and harms of screening mammography.
This article attempts to bound uncertainty by providing a range of estimates-optimistic and pessimistic--on the absolute frequency of 3 outcomes important to the mammography decision: breast cancer deaths avoided, false alarms, and overdiagnosis. Expand
Screening for breast cancer with mammography.
It is found that breast cancer mortality was an unreliable outcome that was biased in favour of screening, mainly because of differential misclassification of cause of death. Expand
The benefits and harms of breast cancer screening: an independent review
It is concluded that screening reduces breast cancer mortality but that some overdiagnosis occurs, and results from observational studies support the occurrence of over Diagnosis, but estimates of its magnitude are unreliable. Expand
Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial
Annual mammography in women aged 40-59 does not reduce mortality from breast cancer beyond that of physical examination or usual care when adjuvant therapy for breast cancer is freely available. Expand